As of Feb 17
| +0.76 / +2.67%|
The 7 analysts offering 12-month price forecasts for Cardiovascular Systems Inc have a median target of 30.00, with a high estimate of 40.00 and a low estimate of 28.00. The median estimate represents a +2.77% increase from the last price of 29.19.
The current consensus among 8 polled investment analysts is to Buy stock in Cardiovascular Systems Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.